Patterns of Failure for Conservatively Managed Surgical Stage I Uterine Carcinosarcoma
Authors:
- Charles A. LeathCLCharles A. Leath
- T. Michael NumnumTNT. Michael Numnum
- James E. KendrickJKJames E. Kendrick
- Peter J. FrederickPFPeter J. Frederick
- Rodney P. RocconiRRRodney P. Rocconi
- Michael G. ConnerMCMichael G. Conner
- J. Michael StraughnJSJ. Michael Straughn
- 1 July 2009
- journal article
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 19 (5) , 888-891
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- A gynecologic oncology group randomized phase III trial of whole abdominal irradiation (WAI) vs. cisplatin-ifosfamide and mesna (CIM) as post-surgical therapy in stage I–IV carcinosarcoma (CS) of the uterus☆Gynecologic Oncology, 2007
- The use of adjuvant radiation therapy in early endometrial cancer by members of the Society of Gynecologic Oncologists in 2005☆Gynecologic Oncology, 2007
- Systemic therapy for advanced uterine sarcoma: A systematic review of the literatureGynecologic Oncology, 2005
- Adjuvant ifosfamide and cisplatin in patients with completely resected stage I or II carcinosarcomas (mixed mesodermal tumors) of the uterus: a Gynecologic Oncology Group studyGynecologic Oncology, 2005
- Carcinoma of the corpus uteriInternational Journal of Gynecology & Obstetrics, 2003
- The Impact of Adjuvant Radiotherapy on Carcinosarcoma of the UterusGynecologic Oncology, 1998
- The Role of Whole-Pelvic Irradiation in the Treatment of Early-Stage Uterine CarcinosarcomaGynecologic Oncology, 1997
- Adenocarcinoma of the Endometrium: Survival Comparisons of Patients with and without Pelvic Node SamplingGynecologic Oncology, 1995
- Leiomyosarcomas have a poorer prognosis than mixed mesodermal tumours when adjusting for known prognostic factors: the result of a retrospective study of 423 cases of uterine sarcomaBJOG: An International Journal of Obstetrics & Gynaecology, 1992
- Treatment of uterine sarcomasCancer, 1990